BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 20093497)

  • 1. Hepato-renal pathology in pkd2ws25/- mice, an animal model of autosomal dominant polycystic kidney disease.
    Stroope A; Radtke B; Huang B; Masyuk T; Torres V; Ritman E; LaRusso N
    Am J Pathol; 2010 Mar; 176(3):1282-91. PubMed ID: 20093497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Cdc25A suppresses hepato-renal cystogenesis in rodent models of polycystic kidney and liver disease.
    Masyuk TV; Radtke BN; Stroope AJ; Banales JM; Masyuk AI; Gradilone SA; Gajdos GB; Chandok N; Bakeberg JL; Ward CJ; Ritman EL; Kiyokawa H; LaRusso NF
    Gastroenterology; 2012 Mar; 142(3):622-633.e4. PubMed ID: 22155366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and functional analyses of liver cysts from the BALB/c-cpk mouse model of polycystic kidney disease.
    Muchatuta MN; Gattone VH; Witzmann FA; Blazer-Yost BL
    Exp Biol Med (Maywood); 2009 Jan; 234(1):17-27. PubMed ID: 18997107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3',5'-cyclic monophosphate.
    Masyuk TV; Masyuk AI; Torres VE; Harris PC; Larusso NF
    Gastroenterology; 2007 Mar; 132(3):1104-16. PubMed ID: 17383431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pck rat: a new model that resembles human autosomal dominant polycystic kidney and liver disease.
    Lager DJ; Qian Q; Bengal RJ; Ishibashi M; Torres VE
    Kidney Int; 2001 Jan; 59(1):126-36. PubMed ID: 11135065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCR2 agonists in ADPKD liver cyst fluids promote cell proliferation.
    Amura CR; Brodsky KS; Gitomer B; McFann K; Lazennec G; Nichols MT; Jani A; Schrier RW; Doctor RB
    Am J Physiol Cell Physiol; 2008 Mar; 294(3):C786-96. PubMed ID: 18199703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ttc21b deficiency attenuates autosomal dominant polycystic kidney disease in a kidney tubular- and maturation-dependent manner.
    Wang W; Silva LM; Wang HH; Kavanaugh MA; Pottorf TS; Allard BA; Jacobs DT; Dong R; Cornelius JT; Chaturvedi A; Swenson-Fields KI; Fields TA; Pritchard MT; Sharma M; Slawson C; Wallace DP; Calvet JP; Tran PV
    Kidney Int; 2022 Sep; 102(3):577-591. PubMed ID: 35644283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dnajb11-Kidney Disease Develops from Reduced Polycystin-1 Dosage but not Unfolded Protein Response in Mice.
    Ghosh Roy S; Li Z; Guo Z; Long KT; Rehrl S; Tian X; Dong K; Besse W
    J Am Soc Nephrol; 2023 Sep; 34(9):1521-1534. PubMed ID: 37332102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Hedgehog signaling suppresses proliferation and microcyst formation of human Autosomal Dominant Polycystic Kidney Disease cells.
    Silva LM; Jacobs DT; Allard BA; Fields TA; Sharma M; Wallace DP; Tran PV
    Sci Rep; 2018 Mar; 8(1):4985. PubMed ID: 29563577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The regulatory 1α subunit of protein kinase A modulates renal cystogenesis.
    Ye H; Wang X; Constans MM; Sussman CR; Chebib FT; Irazabal MV; Young WF; Harris PC; Kirschner LS; Torres VE
    Am J Physiol Renal Physiol; 2017 Sep; 313(3):F677-F686. PubMed ID: 28615245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirolimus attenuates disease progression in an orthologous mouse model of human autosomal dominant polycystic kidney disease.
    Zafar I; Ravichandran K; Belibi FA; Doctor RB; Edelstein CL
    Kidney Int; 2010 Oct; 78(8):754-61. PubMed ID: 20686448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney stone formation in a novel murine model of polycystic kidney disease.
    Riddle HAL; Zhang S; Qian F; Williams JC; Stubbs JR; Rowe PSN; Parnell SC
    Am J Physiol Renal Physiol; 2022 Jul; 323(1):F59-F68. PubMed ID: 35343849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic cystogenesis is associated with abnormal expression and location of ion transporters and water channels in an animal model of autosomal recessive polycystic kidney disease.
    Banales JM; Masyuk TV; Bogert PS; Huang BQ; Gradilone SA; Lee SO; Stroope AJ; Masyuk AI; Medina JF; LaRusso NF
    Am J Pathol; 2008 Dec; 173(6):1637-46. PubMed ID: 18988797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PKD1 mono-allelic knockout is sufficient to trigger renal cystogenesis in a mini-pig model.
    He J; Li Q; Fang S; Guo Y; Liu T; Ye J; Yu Z; Zhang R; Zhao Y; Hu X; Bai X; Chen X; Li N
    Int J Biol Sci; 2015; 11(4):361-9. PubMed ID: 25798056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct patterns of kidney and liver cyst growth in pkd2(WS25/-) mice.
    Doctor RB; Serkova NJ; Hasebroock KM; Zafar I; Edelstein CL
    Nephrol Dial Transplant; 2010 Nov; 25(11):3496-504. PubMed ID: 20388629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathological analysis of renal cystic epithelia in the Pkd2WS25/- mouse model of ADPKD.
    Thomson RB; Mentone S; Kim R; Earle K; Delpire E; Somlo S; Aronson PS
    Am J Physiol Renal Physiol; 2003 Nov; 285(5):F870-80. PubMed ID: 12851251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gα12 is required for renal cystogenesis induced by Pkd1 inactivation.
    Wu Y; Xu JX; El-Jouni W; Lu T; Li S; Wang Q; Tran M; Yu W; Wu M; Barrera IE; Bonventre JV; Zhou J; Denker BM; Kong T
    J Cell Sci; 2016 Oct; 129(19):3675-3684. PubMed ID: 27505895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VEGF receptor inhibition blocks liver cyst growth in pkd2(WS25/-) mice.
    Amura CR; Brodsky KS; Groff R; Gattone VH; Voelkel NF; Doctor RB
    Am J Physiol Cell Physiol; 2007 Jul; 293(1):C419-28. PubMed ID: 17475663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenylyl cyclase 5 links changes in calcium homeostasis to cAMP-dependent cyst growth in polycystic liver disease.
    Spirli C; Mariotti V; Villani A; Fabris L; Fiorotto R; Strazzabosco M
    J Hepatol; 2017 Mar; 66(3):571-580. PubMed ID: 27826057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease.
    Munoz-Garrido P; Marin JJ; Perugorria MJ; Urribarri AD; Erice O; Sáez E; Úriz M; Sarvide S; Portu A; Concepcion AR; Romero MR; Monte MJ; Santos-Laso Á; Hijona E; Jimenez-Agüero R; Marzioni M; Beuers U; Masyuk TV; LaRusso NF; Prieto J; Bujanda L; Drenth JP; Banales JM
    J Hepatol; 2015 Oct; 63(4):952-61. PubMed ID: 26044126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.